ArticleInfection and drug resistance2011

Critical appraisal of a quadrivalent CRM(197) conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo) in the context of treatment and prevention of invasive disease.

Michael Bröker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.